Fractyl Health (GUTS) Current Assets (2023 - 2026)
Fractyl Health's (GUTS) quarterly Current Assets came in at $65.9 million in Q1 2026, up 40.12% YoY from $47.0 million in Q1 2025, and down 24.73% on a QoQ basis from $87.6 million in Q4 2025.
Fractyl Health (GUTS) Current Assets (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Current Assets data on file, last reported at $65.9 million in Q1 2026.
- Quarterly Current Assets rose 40.12% year-over-year to $65.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.9 million (up 40.12% YoY) and the FY2025 annual result came in at $87.6 million, up 22.04% from the prior year.
- Current Assets declined to $65.9 million in Q1 2026, from $87.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $124.5 million in Q1 2024 to a low of $26.7 million in Q2 2025.
- A 4-year average of $73.3 million and a median of $75.7 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets surged 101.31% — and 2025, when it tumbled 74.95%.
- Tracing GUTS's Current Assets over 4 years: stood at $35.6 million in 2023, then jumped by 101.31% to $71.8 million in 2024, then climbed by 22.04% to $87.6 million in 2025, then slipped by 24.73% to $65.9 million in 2026.
- The last three Current Assets figures came in at $65.9 million (Q1 2026), $87.6 million (Q4 2025), and $79.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | 1.76 Bn |
| 10 | Fractyl Health | 126.17 Mn | 126.17 Mn | - | 49.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.60 Mn |
| Mar 31, 2026 | 65.92 Mn |
| Dec 31, 2025 | 87.58 Mn |
| Sep 30, 2025 | 79.70 Mn |
| Jun 30, 2025 | 26.69 Mn |
| Mar 31, 2025 | 47.05 Mn |
| Dec 31, 2024 | 71.76 Mn |
| Sep 30, 2024 | 87.65 Mn |
| Jun 30, 2024 | 106.56 Mn |
| Mar 31, 2024 | 124.47 Mn |
| Dec 31, 2023 | 35.65 Mn |